A

Aulos Bioscience

11 employees

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
immuno oncology
Health Care
Therapeutics
Medical
oncology
cancer research
Life Science
monoclonal antibodies

Date founded

2020

Funding rounds raised

Total raised

$40M

from 1 investors over 1 rounds

A

Aulos Bioscience raised $40M on January 8, 2021

Investors: ATP (Apple Tree Partners)

FAQ